Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:STSA

Satsuma Pharmaceuticals (STSA) Stock Price, News & Analysis

Satsuma Pharmaceuticals logo

About Satsuma Pharmaceuticals Stock (NASDAQ:STSA)

Advanced Chart

Key Stats

Today's Range
$1.10
$1.10
50-Day Range
$1.04
$1.11
52-Week Range
$0.59
$8.08
Volume
N/A
Average Volume
701,788 shs
Market Capitalization
$36.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Satsuma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

STSA Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Satsuma Pharmaceuticals Inc (STSA)
SNBL’s Subsidiary Resubmits Migraine Drug Application
See More Headlines

STSA Stock Analysis - Frequently Asked Questions

Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) released its earnings results on Tuesday, November, 9th. The financial services provider reported ($0.42) earnings per share for the quarter, beating the consensus estimate of ($0.51) by $0.09.

Satsuma Pharmaceuticals (STSA) raised $75 million in an IPO on Friday, September 13th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Credit Suisse, SVB Leerink and Evercore acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Satsuma Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

Last Earnings
11/09/2021
Today
7/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Regional Banks
Current Symbol
NASDAQ:STSA
CIK
891106
Fax
N/A
Employees
21
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
($2.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.06 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-115.24%
Return on Assets
-102.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.44
Quick Ratio
7.44

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.41 per share
Price / Book
0.78

Miscellaneous

Outstanding Shares
33,150,000
Free Float
22,809,000
Market Cap
$36.47 million
Optionable
Not Optionable
Beta
0.10

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:STSA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners